Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063802

Chief Commercial Officer gave up 498 shares (to pay taxes)

  • Chief Commercial Officer acquired 1,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fair Brett Chief Commercial Officer 2018-12-18 Option exercise +1,750 8,513 D
Fair Brett Chief Commercial Officer 2018-12-18 Shares withheld for taxes −498 $6.30 $3,137 8,015 D
Derivatives
Fair Brett Chief Commercial Officer 2018-12-18 Option exercise · Restricted Stock Units −1,750 1,750 D
Loading xslF345X03/doc4.xml…